HJ declines, for the 15th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The archive
Page 13 of 170 of this archive, newest first.
The 24-day notice: how a compounding wind-down works in the United Kingdom
The document is four pages. Three of them are about dates.
The named comparison we promised two years ago
Duplicate submissions under different names test within-laboratory repeatability, which is a different quantity from between-laboratory reproducibility.
Adsorption, and the dose that stayed on the glass
Bacteriostatic water contains benzyl alcohol at 0.9 per cent, which inhibits microbial growth in a preserved multiple-dose presentation. It does not sterilise a contaminated…
Why the bone question is harder than the muscle question
A plausible mechanism, a measurable change, and no outcome data. This is what an open question looks like.
Germany caps semaglutide prescribing to 14 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What changed at Homopeptide in April, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
A supplier suspends shipping to Norway after 13 consecutive customs detentions
The route did not close because of a rule about peptides.
Why a drug that acts on the pancreas changes what food tastes like
Receptor expression maps explain the effect profile better than any dose-response curve.
SURMOUNT-2 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Argentina caps semaglutide prescribing to 17 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The 8-day notice: how a compounding wind-down works in the United Arab Emirates
The document is four pages. Three of them are about dates.
From the floor in Shenzhen: 23 posters, one theme
Reported from the sessions, and from the two hours afterwards.
One vial, four weeks, and the data that does not exist
At low concentrations a measurable fraction of peptide can adsorb to glass and plastic surfaces, and the loss is largest exactly where it is least expected.
Gastric emptying is a mechanism, not a side effect
The central effects are not a bonus. On the current evidence they are the principal mechanism of weight loss.
SUSTAIN-6 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Independent analysis puts a MKM cagrilintide lot at 97.3%, against 95.9% on the certificate
The supplier has not disputed the finding. It has not explained the gap either.
The quiet end of the relabeller trading as Vantris Bio
A proper account of an operation that existed, and of what closing it cost.
A supplier suspends shipping to Mexico after 5 consecutive customs detentions
The route did not close because of a rule about peptides.
Seasonal use, holiday use, and the honest state of the evidence
A great deal of practice has grown up around intermittent schedules. The randomised evidence for any of them is, as far as the Journal can establish, nil.
The imaging substudy is an afterthought in the protocol and the centrepiece of the debate
The trials measured mass. Nobody measured whether the participants got weaker.
The supply gap as a clinical event
Cost is the modal reason for discontinuation in every dataset we have seen, and it is absent from the clinical literature.
What changed at QST in April, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
PeptideMeter result on a Changsha mazdutide lot lands 1.3 points below the supplier’s figure
A reminder that a purity figure is the output of a method, and that methods differ.
Inspectors cite the relabeller trading as Vantris Bio over sterility assurance
The observation that closes a facility is rarely the dramatic one.
What the new Argentina guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
Janoshik, Medutest, PeptideMeter, VendorInvestigate: a capability audit
We asked all four services what they can determine, on what timescale, at what price, and under what accreditation. The answers are printed in full.
The 13-day notice: how a compounding wind-down works in South Africa
The document is four pages. Three of them are about dates.
Inspectors cite Calder Vale Peptides of Skipton over sterility assurance
The observation that closes a facility is rarely the dramatic one.
Ireland declines to reimburse liraglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.